Nemaura Medical Inc.
NMRD
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.80% | 3.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.83% | -0.37% | |||
| Operating Income | 24.83% | 0.37% | |||
| Income Before Tax | -79.60% | 53.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -79.60% | 53.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -79.60% | 53.77% | |||
| EBIT | 24.83% | 0.37% | |||
| EBITDA | 23.89% | 2.08% | |||
| EPS Basic | -79.81% | 53.83% | |||
| Normalized Basic EPS | -79.62% | 53.82% | |||
| EPS Diluted | -49.60% | 44.51% | |||
| Normalized Diluted EPS | -79.62% | 53.82% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||